These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 573920)

  • 21. [Studies on the usefulness of double filtration plasmapheresis in a hemophilia A patient with anti-factor VIII antibody (inhibitor)].
    Okubo S; Ikuma T; Hamaguchi Y; Yasunaga K
    Rinsho Ketsueki; 1985 May; 26(5):701-8. PubMed ID: 3932716
    [No Abstract]   [Full Text] [Related]  

  • 22. Overview of inhibitors.
    Astermark J
    Semin Hematol; 2006 Apr; 43(2 Suppl 4):S3-7. PubMed ID: 16690373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of anti-factor VIII antibodies.
    Blatt PM; White GC; McMillan CW; Roberts HR
    Thromb Haemost; 1977 Aug; 38(2):514-23. PubMed ID: 579493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Haemophilia--darkest hours before the dawn.
    Street AM; Ekert H
    Med J Aust; 1996 Apr; 164(8):453-5. PubMed ID: 8614331
    [No Abstract]   [Full Text] [Related]  

  • 25. Immunologic properties of antihemophilic factor.
    Hoyer LW
    Prog Hematol; 1973; 8():191-221. PubMed ID: 4545112
    [No Abstract]   [Full Text] [Related]  

  • 26. Letter: Fresh-platelet transfussions in haemophilic patients with factor-VIII antibody.
    Bloom AL; Hutton RD
    Lancet; 1975 Aug; 2(7930):369-70. PubMed ID: 51178
    [No Abstract]   [Full Text] [Related]  

  • 27. Discordant antibody response in monozygotic twins with severe haemophilia A caused by intensive treatment.
    Gouw SC; ter Avest PC; van Helden PM; Voorberg J; van den Berg HM
    Haemophilia; 2009 May; 15(3):712-7. PubMed ID: 19432924
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kinetics of the inhibitor of factor VIII:C in patients with hemophilia A. A study of the cooperative group of hemophilia.
    Ambriz-Fernández R; Reyna-Fregoso MP; Pizzuto-Chávez J; Rodríguez-Moyado H; Farfán-Canto JM; Trueba-Christy E; Collazo-Jaloma J
    Arch Invest Med (Mex); 1985; 16(3):225-35. PubMed ID: 3938639
    [No Abstract]   [Full Text] [Related]  

  • 29. Immune tolerance by intermittent factor VIII boluses in two high responder hemophilia A patients.
    Landolfi R; de Cristofaro R; Lazzareschi I; Riccardi R; Mariani G
    Haematologica; 2000 Oct; 85(10 Suppl):73-4. PubMed ID: 11187877
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comments on the development of inhibitor antibodies in patients using recombinant factor VIII concentrates.
    Brettler DB
    Semin Hematol; 1991 Apr; 28(2 Suppl 1):45-6. PubMed ID: 1908128
    [No Abstract]   [Full Text] [Related]  

  • 31. The epidemiology of factor VIII inhibitors.
    Hay CR
    Haemophilia; 2006 Dec; 12 Suppl 6():23-8; discussion 28-9. PubMed ID: 17123390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factor VIII inhibitors in mild and moderate-severity haemophilia A. UK Haemophilia Centre Directors Organisation.
    Hay CR; Ludlam CA; Colvin BT; Hill FG; Preston FE; Wasseem N; Bagnall R; Peake IR; Berntorp E; Mauser Bunschoten EP; Fijnvandraat K; Kasper CK; White G; Santagostino E
    Thromb Haemost; 1998 Apr; 79(4):762-6. PubMed ID: 9569189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemophilia treatment. Gene therapy, factor VIII antibodies and immune tolerance: hopes and concerns.
    Lillicrap D
    Haematologica; 2000 Oct; 85(10 Suppl):108-11; discussion 111-2. PubMed ID: 11187861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitors to factor VIII in a family with mild hemophilia: molecular characterization and response to factor VIII and desmopressin.
    Santagostino E; Gringeri A; Tagliavacca L; Mannucci PM
    Thromb Haemost; 1995 Aug; 74(2):619-21. PubMed ID: 8584995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of frequent factor VIII replacement on the level of factor VIII antibodies in haemophiliacs.
    Rizza CR; Matthews JM
    Br J Haematol; 1982 Sep; 52(1):13-24. PubMed ID: 6810911
    [No Abstract]   [Full Text] [Related]  

  • 36. Antibodies to factor VIII. V. Patterns of immune response to factor VIII in hemophilia A.
    Allain JP; Frommel D
    Blood; 1976 Jun; 47(6):973-82. PubMed ID: 1276479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pair comparison of the jaw development in monozygotic twins].
    Klink-Heckmann U; Dahl T
    Zahn Mund Kieferheilkd Zentralbl; 1977; 65(7):762-9. PubMed ID: 146367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histocompatibility antigen patterns in haemophilic patients with factor VIII antibodies.
    Aly AM; Aledort LM; Lee TD; Hoyer LW
    Br J Haematol; 1990 Oct; 76(2):238-41. PubMed ID: 2128808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The missense mutation Arg593 --> Cys is related to antibody formation in a patient with mild hemophilia A.
    Fijnvandraat K; Turenhout EA; van den Brink EN; ten Cate JW; van Mourik JA; Peters M; Voorberg J
    Blood; 1997 Jun; 89(12):4371-7. PubMed ID: 9192760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [An immunological study in hemophiliacs].
    Sturm JA; Azevedo CB; Baré LF; Gonzaga AL
    AMB Rev Assoc Med Bras; 1982 Jan; 28(1):1-4. PubMed ID: 6820523
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.